BioSpace News Archive

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the first patient has been enrolled in Mirum’s Phase 2b VISTAS study evaluating volixibat in adult patients with primary sclerosing cholangitis (PSC), an idiopathic chronic cholestatic liver disease characterized by progressive inflammation and destruction of bile ducts often leading to serious liver disease, cancer, and ultimately liver failure.

Leading industry publication calls attention to ongoing challenges in the electrophysiology lab PURE EP System is highlighted as a novel technological solution BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the PURE EP

According to the research report published by Fact.MR accessories & consumables, and auto-samplers are expected to emerge as the fastest-selling products in the global gas chromatography market.

Chromatography pump is an associated equipment of overall chromatography system. These pumps are used to pass a pressurized liquid solvent containing the sample mixture through a column filled with a solid adsorbent material, leading to the separation of the sample components.

OCT ophthalmoscope is a device used in optical coherence tomography (OCT) for examining the interior of the human eye by means of a beam of light, which illuminates otherwise invisible tissues

According to the report, the global plasma feed market was valued at US$ 2.4 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030.

According to the report, the global pressure relief devices market was valued at US$ 2.6 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030.

Turner Syndrome is a genetic disorder which is known to affect only females. It is caused when one of the X chromosomes (sex chromosomes) is missing or partially missing.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces it has completed enrollment in its pilot clinical study evaluating the efficacy and safety of ensifentrine delivered via pressurized metered-dose inhaler formulation in U.S.

Hutchison China MediTech Limited announces that the final analysis of savolitinib in Phase Ib TATTON study Parts B and D will be presented at the upcoming virtual 2020 World Conference on Lung Cancer, taking place on January 28-31, 2021, virtually.